These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 197474

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Pulmonary lipiodol miliaria. Complications of hysterosalpingography and of vascular accidents].
    Claus E, Dochez C.
    J Belge Radiol; 1966; 49(1):18-24. PubMed ID: 4286033
    [No Abstract] [Full Text] [Related]

  • 4. The management of massive pulmonary embolism following hysterosalpingography.
    Hodge J, Price AH.
    J S C Med Assoc; 1969 Sep; 65(9):315-9. PubMed ID: 4310346
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Adverse reactions to lipiodol ultra fluid: report of an accidental case.
    Ogihara T, Miyao H, Katoh H, Ikenaga H, Michikawa N, Ohkubo N, Kasahara M, Iyori S.
    Keio J Med; 1991 Jun; 40(2):94-6. PubMed ID: 1652663
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prolonged oviduct retention of iodized contrast medium.
    Malter IJ, Fox RM.
    Obstet Gynecol; 1972 Aug; 40(2):221-4. PubMed ID: 4340146
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cutaneous reactions at test sites of iodine-containing contrast medium.
    Watanabe S, Watanabe S.
    Arch Dermatol; 1980 Feb; 116(2):157. PubMed ID: 6243911
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Complications following hysterosalpingography (HSG) (author's transl)].
    Hanus J, Presl J.
    Cesk Gynekol; 1976 Dec; 41(10):751-5. PubMed ID: 1009611
    [No Abstract] [Full Text] [Related]

  • 13. Cerebral embolization and coma after hysterosalpingography with oil-soluble contrast medium.
    Dan U, Oelsner G, Gruberg L, Ezra D, Menczer J.
    Fertil Steril; 1990 May; 53(5):939-40. PubMed ID: 2158910
    [Abstract] [Full Text] [Related]

  • 14. [Therapeutic effect of lipiodol and hysterosalpingography in female sterility].
    Kurdiian SA.
    Zh Eksp Klin Med; 1973 May; 13(3):75-84. PubMed ID: 4365042
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Letter: Female sterility produced by investigation.
    Wright FW, Stallworthy H.
    Br Med J; 1973 Sep 22; 3(5881):632. PubMed ID: 4356871
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Safety and pharmacokinetics of iotrolan in hysterosalpingography. Retention and irritability compared with Lipiodol.
    Miyamoto Y, Tsujimoto T, Iwai K, Ishida K, Uchimoto R, Miyazawa T, Azuma H.
    Invest Radiol; 1995 Sep 22; 30(9):538-43. PubMed ID: 8537211
    [Abstract] [Full Text] [Related]

  • 20. Intravasation during hysterosalpingography using low viscosity oil base contrast media.
    La Sala GB, Ghirardini G, Valli F, Margini F.
    Clin Exp Obstet Gynecol; 1982 Sep 22; 9(4):257-9. PubMed ID: 6301707
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.